Lee's Pharmaceutical Holdings Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lee's Pharmaceutical Holdings.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 11.1% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?
Jan 12In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Lee's Pharmaceutical Holdings onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 1,199 | 63 | 14 | 130 | N/A |
3/31/2024 | 1,126 | 40 | -8 | 120 | N/A |
12/31/2023 | 1,053 | 17 | -30 | 110 | N/A |
9/30/2023 | 980 | 5 | N/A | N/A | N/A |
6/30/2023 | 1,096 | 39 | -133 | 70 | N/A |
3/31/2023 | 1,165 | 39 | N/A | N/A | N/A |
12/31/2022 | 1,233 | 51 | 70 | 284 | N/A |
9/30/2022 | 1,350 | -119 | N/A | N/A | N/A |
6/30/2022 | 1,331 | -140 | 103 | 317 | N/A |
3/31/2022 | 1,308 | 1,966 | N/A | N/A | N/A |
12/31/2021 | 1,266 | 1,987 | -160 | 211 | N/A |
9/30/2021 | 1,275 | 2,176 | N/A | N/A | N/A |
6/30/2021 | 1,244 | 2,188 | -65 | 394 | N/A |
3/31/2021 | 1,227 | 130 | N/A | N/A | N/A |
12/31/2020 | 1,217 | 129 | -139 | 219 | N/A |
9/30/2020 | 1,199 | 167 | N/A | N/A | N/A |
6/30/2020 | 1,168 | 184 | -142 | 179 | N/A |
3/31/2020 | 1,209 | 118 | N/A | N/A | N/A |
12/31/2019 | 1,219 | 126 | 39 | 400 | N/A |
9/30/2019 | 1,185 | 301 | N/A | N/A | N/A |
6/30/2019 | 1,177 | 331 | -43 | 309 | N/A |
3/31/2019 | 1,139 | 395 | N/A | N/A | N/A |
12/31/2018 | 1,138 | 418 | 27 | 321 | N/A |
9/30/2018 | 1,126 | 243 | N/A | N/A | N/A |
6/30/2018 | 1,101 | 233 | 45 | 447 | N/A |
3/31/2018 | 1,064 | 256 | N/A | N/A | N/A |
12/31/2017 | 1,009 | 233 | N/A | 366 | N/A |
9/30/2017 | 981 | 245 | N/A | N/A | N/A |
6/30/2017 | 955 | 256 | N/A | 358 | N/A |
3/31/2017 | 930 | 245 | N/A | N/A | N/A |
12/31/2016 | 930 | 252 | N/A | 395 | N/A |
9/30/2016 | 911 | 259 | N/A | N/A | N/A |
6/30/2016 | 894 | 247 | N/A | 309 | N/A |
3/31/2016 | 917 | 242 | N/A | N/A | N/A |
12/31/2015 | 922 | 229 | N/A | 160 | N/A |
9/30/2015 | 976 | 221 | N/A | N/A | N/A |
6/30/2015 | 990 | 209 | N/A | 140 | N/A |
3/31/2015 | 979 | 191 | N/A | N/A | N/A |
12/31/2014 | 955 | 193 | N/A | 220 | N/A |
9/30/2014 | 874 | 175 | N/A | N/A | N/A |
6/30/2014 | 805 | 164 | N/A | 255 | N/A |
3/31/2014 | 755 | 160 | N/A | N/A | N/A |
12/31/2013 | 697 | 150 | N/A | 179 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if 950's forecast earnings growth is above the savings rate (2.3%).
Winst versus markt: Insufficient data to determine if 950's earnings are forecast to grow faster than the Hong Kong market
Hoge groeiwinsten: Insufficient data to determine if 950's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if 950's revenue is forecast to grow faster than the Hong Kong market.
Hoge groei-inkomsten: Insufficient data to determine if 950's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 950's Return on Equity is forecast to be high in 3 years time